Potassium channels as an ionic checkpoint in tumor immunity

Potassium (K⁺) channels sustain immune-cell activation by coupling K⁺ flux to membrane potential, Ca²⁺ signaling, migration, and metabolic adaptation. In solid tumors, however, extracellular K⁺ accumulation, adenosine, hypoxia, acidosis, oxidative stress, and lipid stress can disrupt ionic homeostasis and channel function. Here, we define an ionic checkpoint as a context-dependent regulatory state in which K⁺ gradients, channel gating and trafficking, membrane potential, and subcellular channel localization determine whether immune cells cross the electrophysiological thresholds required for Ca²⁺ signaling and effector function. We synthesize evidence across adaptive and innate immunity, emphasizing Kv1.3 and KCa3.1 in T- and natural killer-cell responses and dendritic-cell migration, and Kir and K2P channels in myeloid and NK-cell programs. We further examine plasma-membrane-mitochondrial channel crosstalk, redox regulation, and spatial and temporal heterogeneity in the tumor immune microenvironment. Because the same channel may support lymphocyte function while sustaining tumor-cell survival or immunosuppressive myeloid states, neither universal activation nor universal inhibition is appropriate. Direct channel targeting is constrained by cell and organelle selectivity, whereas upstream tumor-microenvironment-directed strategies, particularly adenosine-axis interventions, are clinically more advanced but have not yet established direct restoration of K⁺ channel-supported immune function. Translation will require functional and spatial biomarkers, precision patient stratification, and cell- or organelle-selective delivery.